Latest hum. ProductsDetails
Product Name in the RMS: Docetaxel Nordic 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung
MR Number: DE/H/3509/001
Date of outcome: 26.02.2014
| Type of application | |
|---|---|
|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Initial Application Generic Chemical Substance Prescription Only |
| Active Substances |
docetaxel 20 mg/ml |
| Form | Concentrate for solution for infusion |
| MA Holder in the RMS |
Nordic Group B.V. Siriusdreef 22 2132 WT HOOFDDORP Niederlande |
| RMS | Germany |
| Date of last change | 15.12.2021 |
| ATC-Code |
L01CD02 Docetaxel |
| CMS Country | Domestic Product Name |
|---|---|
| Denmark | |
| Finland | |
| France | |
| Norway | Qvidadotax |
| Sweden | Docetaxel Nordic |
| Documents | |
|---|---|
| PAR: | DE_H_3509_001_PAR.pdf (05.11.2021) |
| FinalSPC: | DE_H_3509_001_FinalSPC_1of3.pdf (11.03.2014) |
| FinalSPC: | DE_H_3509_001_FinalSPC_2of3.pdf (11.03.2014) |
| FinalSPC: | DE_H_3509_001_FinalSPC_3of3.pdf (11.03.2014) |
| FinalPL: | DE_H_3509_001_FinalPL_1of3.pdf (11.03.2014) |
| FinalPL: | DE_H_3509_001_FinalPL_2of3.pdf (11.03.2014) |
| FinalPL: | DE_H_3509_001_FinalPL_3of3.pdf (11.03.2014) |
| FinalLabelling: | DE_H_3509_001_FinalLabelling_1of6.pdf (11.03.2014) |
| FinalLabelling: | DE_H_3509_001_FinalLabelling_2of6.pdf (11.03.2014) |
| FinalLabelling: | DE_H_3509_001_FinalLabelling_3of6.pdf (11.03.2014) |
| FinalLabelling: | DE_H_3509_001_FinalLabelling_4of6.pdf (11.03.2014) |
| FinalLabelling: | DE_H_3509_001_FinalLabelling_5of6.pdf (11.03.2014) |
| FinalLabelling: | DE_H_3509_001_FinalLabelling_6of6.pdf (11.03.2014) |
| Finalised Product Information: | DE_H_3509_001_FinalPI_1of2.pdf (21.09.2021) |
| Finalised Product Information: | DE_H_3509_001_FinalPI_2of2.pdf (21.09.2021) |
